首页|HTRA丝氨酸肽酶1基因相关显性遗传脑小血管病的临床表型及遗传学分析

HTRA丝氨酸肽酶1基因相关显性遗传脑小血管病的临床表型及遗传学分析

扫码查看
目的 探讨HTRA丝氨酸肽酶1(HTRA1)基因杂合突变所致脑小血管病(CSVD)的临床表型及遗传学特征.方法 选取2020年1月至2023年12月中南大学湘雅医院老年医学科、神经内科确诊的9例HTRA1基因相关显性遗传CSVD患者为研究对象,收集其临床资料,应用全外显子测序法对先证者进行基因检测,并通过Sanger测序对家系进行验证,总结其临床及遗传学特点.结果 9例HTRA1基因相关显性遗传CSVD患者的起病年龄为(51.1±9.5)岁,认知障碍、卒中发作和步态障碍是其最常见的临床表现,磁共振成像检查常见弥漫性脑白质病变、多发腔隙性脑梗死、多发脑微出血以及脑萎缩,符合CSVD影像学改变特点.大部分患者脑脊液出现Aβ42水平以及Aβ42/Aβ40比值下降,2/4的患者有磷酸化tau蛋白水平上升.9例患者中发现了 7种HTRA1基因的杂合突变,其中有2个为新突变,分别为c.1160T>C(p.M387T)和c.569G>T(p.A190L)杂合错义突变.结论 HTRA1基因相关显性遗传CSVD患者的临床表现以认知障碍、卒中发作和步态障碍为主,影像学特征符合CVSD改变.HTRA1基因c.1160T>C(p.M387T)和c.569G>T(p.A190L)杂合错义突变是新报道的突变,扩展了本病的基因突变谱.
High-temperature requirement A serine peptidase 1 gene-related autosomal dominant cerebral small vessel disease:clinical and genetic characteristics
Objective To investigate the clinical phenotype and genetic characteristics of cerebral small vessel disease(CSVD)caused by heterozygous mutations in high-temperature requirement A serine peptidase 1(HTRA1)gene.Methods Nine patients with HTRA1 gene related autosomal dominant CSVD diagnosed in the Departments of Geriatrics and Neurology,Xiangya Hospital of Central South University between January 2020 and December 2023 were selected.Their clinical data were collected,and the probands received genetic test using whole exome sequencing.The mutations were then verified in the family using Sanger sequencing,and their clinical and genetic characteristics were summarized.Results Among the 9 patients with HTRA1 gene related autosomal dominant CSVD,the onset age was(51.1±9.5)years.Cognitive impairment,stroke onset,and gait disturbance were the most common clinical manifestations.Magnetic resonance imaging examination usually revealed diffuse white matter lesions,multiple lacunar cerebral infarction,multiple cerebral microbleeds,and brain atrophy,which were consistent with the radiological characteristics of CSVD.Most patients showed a decrease in Aβ42 levels and Aβ42/Aβ40 ratio in cerebrospinal fluid,and 2/4 of patients had an increase in phosphory protein tau levels.Seven heterozygous mutations in the HTRA1 gene were found in 9 patients,including two new heterozygous missense mutations,c.1160T>C(p.M387T)and c.569G>T(p.A190L).Conclusions The clinical manifestations of HTRA1 gene-related autosomal dominant CSVD patients are mainly cognitive impairment,stroke and gait disturbance,and the imaging features are consistent with CVSD changes.HTRA1 gene c.1160T>C(p.M387T)and c.569G>T(p.A190L)heterozygous missense mutations are newly reported mutations,expanding the genetic mutation spectrum of this disease.

Cerebral small vessel diseaseHigh-temperature requirement A serine peptidase 1Mutation

陈晓宇、田芸、王鸿、谷文萍、易芳

展开 >

中南大学湘雅医院神经外科,长沙 410008

中南大学湘雅医院老年医学科,长沙 410008

中南大学湘雅医院神经内科,长沙 410008

脑小血管病 HTRA丝氨酸肽酶1 突变

湖南省重点研发计划湖南省自然科学基金

2023SK20192023JJ30966

2024

中华神经科杂志
中华医学会

中华神经科杂志

CSTPCD北大核心
影响因子:1.329
ISSN:1006-7876
年,卷(期):2024.57(8)